Faron Pharmaceuticals Oy Cash Flow-to-Debt Ratio
Faron Pharmaceuticals Oy cash flow-to-debt ratio. Faron Pharmaceuticals Oy (FARN) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2025, meaning its operating cash flow of GBX-5.21K could theoretically repay 0% of its total liabilities (GBX32.45 Million) in one year. See FARN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Faron Pharmaceuticals Oy (2012–2024)
Cash flow-to-debt ratio of Faron Pharmaceuticals Oy from 2012 to 2024. Historical debt coverage capacity for Faron Pharmaceuticals Oy across 13 annual periods. Check FARN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Faron Pharmaceuticals Oy Cash Flow-to-Debt Ratio by Year (2012–2024)
Faron Pharmaceuticals Oy cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Faron Pharmaceuticals Oy. For the full cash flow conversion analysis, see FARN cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.03x | GBX-22.97 Million | GBX22.28 Million | ▼ -9.9% |
| 2023 | -0.94x | GBX-23.81 Million | GBX25.38 Million | ▲ +7.2% |
| 2022 | -1.01x | GBX-22.99 Million | GBX22.75 Million | ▲ +53.3% |
| 2021 | -2.16x | GBX-22.22 Million | GBX10.26 Million | ▼ -26.5% |
| 2020 | -1.71x | GBX-17.48 Million | GBX10.22 Million | ▼ -27.7% |
| 2019 | -1.34x | GBX-11.52 Million | GBX8.60 Million | ▼ -49734.5% |
| 2018 | 0.00x | GBX-20.52K | GBX7.63 Million | ▲ +99.9% |
| 2017 | -1.81x | GBX-18.36 Million | GBX10.14 Million | ▼ -37.2% |
| 2016 | -1.32x | GBX-8.45 Million | GBX6.40 Million | ▲ +32.7% |
| 2015 | -1.96x | GBX-7.15 Million | GBX3.64 Million | ▼ -1590.8% |
| 2014 | -0.12x | GBX-389.00K | GBX3.35 Million | ▲ +51.9% |
| 2013 | -0.24x | GBX-768.00K | GBX3.19 Million | ▲ +70.5% |
| 2012 | -0.82x | GBX-2.27 Million | GBX2.77 Million | — |